Home > Journals > Medicine > Bulletin du cancer > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Bulletin du Cancer
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Cannabis and cancer


Bulletin du Cancer. Volume 93, Number 2, 163-70, Février 2006, Synthèse

Résumé   Article gratuit  

Author(s) : Stéphane Vignot, Benjamin Besse, Thibault de la Motte Rouge, Christophe Massard, Jean-Philippe Spano, Laurent Karila

Summary : The two varieties of hemp, Cannabis sativa and Cannabis indica, contain about sixty compounds, named cannabinoids. The most abundant molecule, Δ 9-tetrahydrocannabinol (THC), is involved in the biological effects of cannabis due to its analogy with endogenous substances (endocannabinoids) thus activating specific receptors : CB1 and CB2. A better knowledge of cannabinoids and their receptors leds to new interrogations, beyond the addictology, in particular in oncology. This review of the literature analyses these questions with special concern on the carcinogenic role of cannabis, the potential antitumor effect of cannabinoids and the place of THC and its derivatives for supportive care in cancerology.

Keywords : cannabis, cannabinoide, tetrahydrocannabinol, cancer

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]